[vc_row][vc_column width=”1/3″][vc_single_image image=”10322″ img_size=”235 x 235″ alignment=”center”][/vc_column][vc_column width=”1/3″][vc_single_image image=”10982″ img_size=”450 x 450″ alignment=”center”][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text]Earlier this year, as part of Vice President Biden’s Cancer Moonshot initiative, the White House established a Blue Ribbon Panel of experts to report on the current challenges and opportunities facing cancer research.

In this CAC2 Research Interest Group webinar for September1 2016, CAC2 welcomed Blue Ribbon Panel members Dr. Peter Adamson (Chair of the Children’s Oncology Group) and David Arons (CEO of the National Brain Tumor Society) in a discussion of the panel’s recently issued report and its implications for pediatric cancer.[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_video link=”https://youtu.be/QGlWWQrcBlo” align=”center”][/vc_column][/vc_row]